| ARHGEF26 | Rho Guanine Nucleotide Exchange Factor 26 |
| ASSAIL-MI | ASSessing the Effect of Anti-IL-6 Treatment in Myocardial Infarction |
| C1S | Complement Component 1 Subcomponent S |
| C2 | Complement Component 2 |
| CAD | Coronary Artery Disease |
| CANTOS | Canakinumab Antiinflammatory Thrombosis Outcome Study |
| CD | Cluster of Differentiation |
| CFTR | Cystic Fibrosis Transmembrane Conductance Regulator |
| CRE | cis-Regulatory Elements |
| CRISPR-Cas9 | Clustered Regularly Interspaced Short Palindromic Repeats- CRISPR-associated protein 9 |
| CXCL1 | C-X-C Motif Chemokine Ligand 1 |
| CXCL12 | C-X-C Motif Chemokine 12 |
| CXCR4 | C-X-C Chemokine Receptor Type 4 |
| DHX58 | DExH-Box Helicase 58 |
| eQTL | Expression Quantitative Trait Locus |
| GUCY1A1 | Guanylate Cyclase 1 Soluble Subunit Alpha 1 |
| GWAS | Genome-Wide Association Study |
| GxE | Gene-Environment Interaction |
| HDAC9 | Histone Deacetylase 9 |
| IKK | IκB Kinase |
| IL | Interleukin |
| IL6R | Interleukin-6 Receptor |
| ITGB5 | Integrin Beta 5 |
| JCAD/KIAA1462 | Junctional Cadherin 5 Associated |
| MRAS | Muscle RAS Oncogene Homolog |
| mRNA | Messenger Ribonucleic Acid |
| NLRP3 | NOD-, LRR- And Pyrin Domain-Containing Protein 3 |
| PCSK9 | Proprotein Convertase Subtilisin/Kexin Type 9 |
| PECAM-1 | Platelet Endothelial Cell Adhesion Molecule 1 |
| PLG | Plasminogen |
| pQTL | Protein Quantitative Trait Locus |
| PRKCE | Protein Kinase C Epsilon |
| PRS | Polygenic Risk Score |
| PRXL2A/FAM213A | Peroxiredoxin Like 2A |
| RCT | Randomized, Controlled Trial |
| SGEF | Src Homology 3 Domain-Containing Guanine Nucleotide Exchange Factor |
| SH2B3/LNK | SH2B Adapter Protein 3/Lymphocyte Adapter Protein |
| SNP | Single Nucleotide Polymorphism |
| SVEP1 | Sushi, Von Willebrand Factor Type A, EGF and Pentraxin Domain-Containing Protein 1 |
| TLR-4 | Toll-Like-Receptor 4 |
| TNF | Tumor Necrosis Factor |
| TRIM | Tripartite Motif Containing |